GENFLOW is dedicated to the development and commercialization of novel therapeutics targeting aging in dogs and humans.
Business Model:
Revenue: $0
Employees: 1-10
Address: 15 Ingestre Place
City: London
State: england
Zip: W1F 0DU
Country: GB
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
1/17/2022
Ticker Symbol:
GENF
Amount Raised:
$5M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | IPO | $5.1M | 1/2021 | Seed Round | 1 | - |
Longevitytech.fund Longevitytech.fund |
1/2021 | Seed Round | 1 | - |
Longevitytech.fund Longevitytech.fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|